Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
A study at Mount Sinai Health System, New York finds that large-scale asthma research involving…
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
A United Kingdom (UK-based) non-governmental health group, Life for African Mothers (LFAM), has disclosed plans…
Multidrug-resistant tuberculosis (TB) could become a serious public health threat in West Africa unless effective…
The United Nations World Health Organization (WHO) is ramping up its response in north-eastern Nigeria,…
Middle- and lower-income countries now have a higher rate of hypertension than high-income countries. Worldwide,…
An experimental pill could help adults with severe asthma, an early study in The Lancet…
Research into oestrogen receptors may be the key to explaining why some forms of breast…
Increasing the number of men who undergo circumcision and increasing the rates at which women…